Also trades as: MARKSANS.NS (NSE) · $vol 2M
MARKSANS.BO BSE
Marksans Pharma Limited
1W: +6.8%
1M: +22.1%
3M: +18.8%
YTD: +15.5%
1Y: -2.3%
3Y: +213.6%
5Y: +275.2%
₹211.35 ($2.21)
-4.70 (-2.18%)
Weekly Expected Move ±6.2%
₹184
₹197
₹210
₹222
₹235
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
0
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₹95.9B ($1.0B)
52W Range157.25-276.15
Volume63,413
Avg Volume52,684
Beta1.07
Dividend₹0.80
Analyst Ratings
No analyst coverage
Company Info
CEOMark Saldanha
Employees1,141
SectorHealthcare
IndustryDrug Manufacturers - General
IPO Date2005-10-04
Websitemarksanspharma.com
Grandeur
Mumbai 400053
IN
Mumbai 400053
IN
91 22 4001 2000
About Marksans Pharma Limited
Marksans Pharma Limited, together with its subsidiaries, engages in the research and development, manufacturing, marketing, and sale of generic pharmaceutical formulations worldwide. The company offers products in the analgesics, benign prostatic hyperplasia, antidiabetic, epilepsy, anti-inflammatory, hyperparathyroidism, diabetes, antacids, neurology, cardiovascular, hormonal, oncology, gastroenterology, antidiabetic, pain management, gynecology, antifungal, antiulceratives, vitamins, dermatology, cephalosporins, injectables, anti-allergy, antibacterial, and hypertension therapeutic areas. Marksans Pharma Limited was incorporated in 1992 and is headquartered in Mumbai, India.
Latest News
No recent news
Recent Insider Trades
No insider trades found